200 related articles for article (PubMed ID: 36006428)
41. Quantitative classification and radiomics of [
de Koster EJ; Noortman WA; Mostert JM; Booij J; Brouwer CB; de Keizer B; de Klerk JMH; Oyen WJG; van Velden FHP; de Geus-Oei LF; Vriens D;
Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2174-2188. PubMed ID: 35138444
[TBL] [Abstract][Full Text] [Related]
42. Prognostic modeling for patients with colorectal liver metastases incorporating FDG PET radiomic features.
Rahmim A; Bak-Fredslund KP; Ashrafinia S; Lu L; Schmidtlein CR; Subramaniam RM; Morsing A; Keiding S; Horsager J; Munk OL
Eur J Radiol; 2019 Apr; 113():101-109. PubMed ID: 30927933
[TBL] [Abstract][Full Text] [Related]
43. Predictive value of
Chen K; Wang J; Li S; Zhou W; Xu W
Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):1869-1880. PubMed ID: 36808002
[TBL] [Abstract][Full Text] [Related]
44. Routine bone marrow biopsy is not necessary in the staging of patients with classical Hodgkin lymphoma in the 18F-fluoro-2-deoxyglucose positron emission tomography era.
Richardson SE; Sudak J; Warbey V; Ramsay A; McNamara CJ
Leuk Lymphoma; 2012 Mar; 53(3):381-5. PubMed ID: 21877882
[TBL] [Abstract][Full Text] [Related]
45. Application of 18 F-fluorodeoxyglucose PET/CT radiomic features and machine learning to predict early recurrence of non-small cell lung cancer after curative-intent therapy.
Park SB; Kim KU; Park YW; Hwang JH; Lim CH
Nucl Med Commun; 2023 Feb; 44(2):161-168. PubMed ID: 36458424
[TBL] [Abstract][Full Text] [Related]
46. Multi-lesion radiomics of PET/CT for non-invasive survival stratification and histologic tumor risk profiling in patients with lung adenocarcinoma.
Zhao M; Kluge K; Papp L; Grahovac M; Yang S; Jiang C; Krajnc D; Spielvogel CP; Ecsedi B; Haug A; Wang S; Hacker M; Zhang W; Li X
Eur Radiol; 2022 Oct; 32(10):7056-7067. PubMed ID: 35896836
[TBL] [Abstract][Full Text] [Related]
47. Prediction of the treatment outcome using machine learning with FDG-PET image-based multiparametric approach in patients with oral cavity squamous cell carcinoma.
Fujima N; Andreu-Arasa VC; Meibom SK; Mercier GA; Salama AR; Truong MT; Sakai O
Clin Radiol; 2021 Sep; 76(9):711.e1-711.e7. PubMed ID: 33934877
[TBL] [Abstract][Full Text] [Related]
48. Deauville Scores 4 or 5 Assessed by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Early Post-Allotransplant Is Highly Predictive of Relapse in Lymphoma Patients.
Bouard L; Bodet-Milin C; Bailly C; Guillaume T; Peterlin P; Garnier A; Bourgeois AL; Mahé B; Dubruille V; Blin N; Touzeau C; Gastinne T; Lok A; Bonnet A; Béné MC; Gouill SL; Moreau P; Kraeber-Bodéré F; Chevallier P
Biol Blood Marrow Transplant; 2019 May; 25(5):906-911. PubMed ID: 30481598
[TBL] [Abstract][Full Text] [Related]
49. Standardized uptake value based evaluation of lymphoma by FDG and FLT PET/CT.
Wang R; Zhu H; Chen Y; Li C; Li F; Shen Z; Tian J; Yu L; Xu B
Hematol Oncol; 2014 Sep; 32(3):126-32. PubMed ID: 23996464
[TBL] [Abstract][Full Text] [Related]
50. 18-Fluorodeoxyglucose positron emission tomography/computed tomography for assessment of response to brentuximab vedotin treatment in relapsed and refractory Hodgkin lymphoma.
Kahraman D; Theurich S; Rothe A; Kuhnert G; Sasse S; Scheid C; Dietlein M; Drzezga A; von Bergwelt-Baildon M; Kobe C
Leuk Lymphoma; 2014 Apr; 55(4):811-6. PubMed ID: 23805904
[TBL] [Abstract][Full Text] [Related]
51. Use of radiomics based on
Zhou Y; Ma XL; Zhang T; Wang J; Zhang T; Tian R
Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2904-2913. PubMed ID: 33547553
[TBL] [Abstract][Full Text] [Related]
52. Prognostic significance of standardized uptake value on F18-FDG PET/CT in patients with extranodal nasal type NK/T cell lymphoma: A multicenter, retrospective analysis.
Pak K; Kim BS; Kim K; Kim IJ; Jun S; Jeong YJ; Shim HK; Kim SD; Cho KS
Am J Otolaryngol; 2018; 39(1):1-5. PubMed ID: 29056243
[TBL] [Abstract][Full Text] [Related]
53.
Cao L; Zhang D; Yang H; Xu W; Liu Y
World J Surg Oncol; 2023 Sep; 21(1):305. PubMed ID: 37749562
[TBL] [Abstract][Full Text] [Related]
54. Robustness of Radiomic Features in [
Lu L; Lv W; Jiang J; Ma J; Feng Q; Rahmim A; Chen W
Mol Imaging Biol; 2016 Dec; 18(6):935-945. PubMed ID: 27324369
[TBL] [Abstract][Full Text] [Related]
55. Performance of FDG PET/CT at initial diagnosis in a rare lymphoma: nodular lymphocyte-predominant Hodgkin lymphoma.
Grellier JF; Vercellino L; Leblanc T; Merlet P; Thieblemont C; Weinmann P; Toubert ME; Berenger N; Brière J; Brice P
Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2023-30. PubMed ID: 24965842
[TBL] [Abstract][Full Text] [Related]
56. Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first-line chemotherapy.
Pedersen MA; Gormsen LC; Kamper P; Wassberg C; Andersen MD; d'Amore AL; Barrington SF; Johnson P; Hamilton-Dutoit S; Amini RM; Enblad G; Molin D; d'Amore F
Br J Haematol; 2019 Aug; 186(3):431-439. PubMed ID: 31115045
[No Abstract] [Full Text] [Related]
57. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging.
Jerusalem G; Beguin Y; Fassotte MF; Najjar F; Paulus P; Rigo P; Fillet G
Blood; 1999 Jul; 94(2):429-33. PubMed ID: 10397709
[TBL] [Abstract][Full Text] [Related]
58. Multimodal deep learning model on interim [
Yuan C; Shi Q; Huang X; Wang L; He Y; Li B; Zhao W; Qian D
Eur Radiol; 2023 Jan; 33(1):77-88. PubMed ID: 36029345
[TBL] [Abstract][Full Text] [Related]
59. Discovery of Pre-Treatment FDG PET/CT-Derived Radiomics-Based Models for Predicting Outcome in Diffuse Large B-Cell Lymphoma.
Frood R; Clark M; Burton C; Tsoumpas C; Frangi AF; Gleeson F; Patel C; Scarsbrook AF
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406482
[TBL] [Abstract][Full Text] [Related]
60. Paediatric and adolescent Hodgkin lymphoma: information derived from diffuse organ uptake of 18 F-fluorodeoxyglucose on pre-treatment and on interim PET/CT.
Jorgov L; Montravers F; Balogova S; Ragu C; Pacquement H; Leblanc T; Abbou S; Ducou-Lepointe H; Landman-Parker J; Talbot JN
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1220-30. PubMed ID: 26660144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
